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Abstract: Background: Centaurea virgata Lam. is a species widely used in the traditional medicine 
in Turkey for the treatment of diabetes, allergy and gastric ulcers. The rationale of its use in the ther-
apy has not been studied previously, therefore the present work aimed at the chemical-
pharmacological evaluation of the plant. Objective: The xanthine oxidase (XO) inhibitory activity of 
the MeOH extract and its subextracts (n-hexane, CHCl3 and remaining MeOH-H2O) prepared from 
C. virgata was investigated in vitro. Moderate activity was exerted in case of the CHCl3 extract (98.9 
± 15.8 g/mL), therefore constituents of this extract were analysed. Method: Different purification 
steps, such as VLC, CPC, PLC and crystallization were used for the isolation, and ESIMS, NMR, 
LC-MS and authentic standards were applied for identification of the compounds. XO inhibitory and 
DPPH assays were used for evaluation of the bioactivities. Results: Sesquiterpenes [8-
hydroxysonchucarpolide, 8-(3,4-dihydroxy-2-methylene-butanoyloxy)-dehydromelitensine, and 
cnicin], flavones (apigenin, hispidulin, salvigenin, eupatorin, 3’-methyleupatorin), and the flavonol 
isokaempferide were isolated from the active extract. The XO-inhibitory activity of these compounds 
was analyzed using allopurinol as a positive control (IC50 7.49 ± 0.29 μM). It was found that ses-
quiterpenes and flavonoids, containing 7-OMe group, are inactive. Conclusion: 7-Hydroxyflavones 
(apigenin and hispidulin) exerted significant XO inhibitory effect with IC50 values of 0.99 ± 0.33 μM 
and 4.88 ± 1.21 μM, respectively. Therefore, these compounds are responsible for the XO-inhibitory 
effect of the extract. The free radical scavenging activity of the isolated flavonoids was determined 
by DPPH assay, and it was stated that none of the compounds have substantial antioxidant activity, 
therefore the reduced generation of reactive oxygen species may be the consequence only of XO in-
hibition. 
Keywords: Centaurea virgata, Asteraceae, xanthine oxidase inhibitory activity, flavonoids, sesquiterpenes. 
1. INTRODUCTION 
The genus Centaurea (Asteraceae) from the tribe Cyna-
rae comprises about 500 species worldwide, and has been the 
object of numerous chemical and pharmacological studies, 
affording the identification of bioactive acetylenes, ses-
quiterpene lactones, flavonoids and lignans as the main char-
acteristic secondary metabolites. In Turkey about 180 Cen-
taurea species are native [1]. C. virgata Lam. is a perennial 
plant with woody base, and rose to purple flowers, which 
grows widely in East Anatolia [1]. Centaurea species are 
widely utilized in the folk medicine in Turkey, and C. vir-
gata has been applied traditionally for the treatment of dia-
betes, allergy and gastric ulcers [2]. The rationale of its tradi- 
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tional application has not been studied previously, therefore 
the present work aimed at the chemical-pharmacological 
evaluation of the plant.  
The enzyme xanthine oxidase (XO) is an important en-
zyme catalyzing the hydroxylation of hypoxanthine to xan-
thine, and xanthine to uric acid. High levels of uric acid in 
the body may result from the deficiency on excretion of this 
substance or by increased production.  
Inhibition of xanthine oxidase reduces the production of 
uric acid, and several medications that inhibit XO are indi-
cated for the treatment of hyperuricemia. Main indication for 
XO inhibitors is the treatment of gout. In addition, recent 
data indicate that XO also plays an important role in various 
forms of ischemic and other types of tissue, vascular injuries 
and inflammatory disorders [3]. 
The present study deals with the determination of the po-
tential of the plant extracts as XO inhibitors, and identifica-
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tion of secondary plant metabolites, including those respon-
sible for the XO-inhibitory activity. 
2. MATERIALS AND METHODS 
2.1. General Experimental Procedures 
1D and 2D NMR spectra were recorded as described in 
[4]. ESIMS was performed on API 2000 triple quadrupole 
mass spectrometer, equipped with an electrospray (ESI) in-
terface (AB SCIEX, Framingham, MA, USA). The source 
temperature was 350 °C. The measurements were carried out 
in positive ionization mode. Data acquisition and evaluation 
were performed using Analyst 1.5.2 software. For open col-
umn chromatography (OCC) silica gel 60 G (0.063-0.2 mm, 
Merck 117734) was used. Vacuum liquid chromatography 
(VLC), centrifugal planar chromatography (CPC) and prepa-
rative TLC were performed as described in [4]. 
2.2. Plant Material 
C. virgata Lam. collected in June 2011, in Elazıg, Tur-
key. The plant material was identified by Assoc. Prof. Ugur 
Cakilcioglu. A voucher specimen (No.1461) has been depos-
ited at the Department of Pharmacognosy, University of Ege. 
3. EXPERIMENTAL 
3.1. Extraction and Isolation 
In a preliminary experiment 10 g of aerial parts of dried 
plant material were extracted with 3  100 mL MeOH by 
ultrasonic bed. After filtration and evaporation, the residue 
was dissolved in 50 mL 50% aqueous MeOH, and solvent-
solvent partition was made first with n-hexane (3  50 mL), 
and then with CHCl3 (3  50 mL). After evaporation n-
hexane, CHCl3 and aqueous MeOH extracts were obtained.  
In the large scale experiment, 1.5 kg of dried plant mate-
rial was extracted with 10 L MeOH. After evaporation, the 
residue was dissolved in 50% aqueous MeOH and was sub-
jected to solvent-solvent partition with n-hexane (5  500 
mL) and CHCl3 (5  500 mL). The evaporated CHCl3 extract 
(16 g) was fractioned by OCC on silica gel using a gradient 
system of n-hexane–acetone-MeOH [9:1:0 (15 L), 8:2:0 (20 
L), 7:3:0 (14 L), 6:4:0 (19 L), 5:5:0 (17 L), 50:50:3 (10 L), 
5:5:0.5 (13 L), 5:5:2 (6 L), 1:1:1 (5 L)]. Fractions were 
monitored by TLC, and combined to ten subfractions (F1–
10). Fractions F6, F7, F8 and F10 were checked by LC-MS 
with the use of authentic standards, and it was found that 
they contain apigenin (4), hispidulin (5), eupatorin (7), 3'-
methyleupatorin (8), and isokaempferide (9). Crystallization 
of the fractions F5, F6, F7 and F8 yielded salvigenin (6) 
(37.8 mg), 3'-methyleupatorin (8) (9.6 mg), eupatorin (7) 
(255.8 mg) and apigenin (4) (42.8 mg), respectively. Frac-
tion F10 was separated by VLC with a gradient system of 
cyclohexane–CHCl3–MeOH (5:9:1, 8:9:1.5, 4:10:1.5, 4:9:2, 
and finally 0:98:2). Two subfractions were yielded (F10/1 
and F10/2). 
F10/1 (1.1577 g) was further fractionated by CPC using a 
gradient system of CHCl3–EtOAc–MeOH (5:5:0, 30:20:2, 
30:20:5, and 30:20:10). Fraction obtained by CHCl3–
EtOAc–MeOH 30:20:2 was subjected to preparative TLC 
and 8-(3,4-dihydroxy-2-methylene-butanoyloxy)-dehydro-
melitensin (2) (31.8 mg) was obtained. 
F10/2 (476.9 mg) was further fractionated by using VLC 
on RP-column with mixtures of MeOH–H2O (3:7, 4:6, 5:5, 
6:4, 7:3, 8:2, and 9:1). Two subfractions were further puri-
fied, and cnicin (3) (2.5 mg) and 8-hydroxysonchucarpolide 
(1) (12.8 mg) were isolated by preparative TLC  
[CHCl3-MeOH (8:2) in case of 3, and toluene–ethyl acetate–
formic acid (3:7:0.5) in case of 1]. 
8-Hydroxysonchucarpolide (1): oily material; 1H-NMR 
(500 MHz, DMSO-d6)  (ppm) 9.42 (1H, d, J = 4.4 Hz, H-
15), 5.93 (1H, d, J = 2.7 Hz, H-13a), 5.87 (1H, d, J = 2.4 Hz, 
H-13b), 5.13 (1H, d, J = 5.7 Hz, 8-OH), 4.74 (1H, d, J = 4.9 
Hz, OH-1), 3.94 (1H, t, J = 11.1 Hz, H-6), 3.83 (1H, m, H-
8), 3.19 (1H, t, J = 4.8 Hz, H-1), 2.53 (1H, t, J = 10.5 Hz, H-
7), 2.32 (1H, m, H-4), 2.10 (1H, dd, J = 13.1, 4.2 Hz, H-9a), 
1.9 (1H, m, H-5), 1.60 (1H, m, H-2a), 1.44 (2H, m, H-2b, H-
3), 1.12 (1H, t, J = 11.7 Hz, H-9b), 0.80 (3H, s, H-14); 13C-
NMR (125 MHz, DMSO-d6)  205.9 (C-14), 170.0 (C-12), 
140.1 (C-11), 120.9 (C-13), 81.1 (C-6), 77.3 (C-1), 67.5 (C-
8), 56.8 (C-7), 49.4 (C-4), 48.8 (C-5, 9), 41.3 (C-10), 29.8 
(C-2), 25.6 (C-3), 14.5 (CH3) ppm; ESIMS positive m/z 298 
[M+NH4]
+, 303 [M+Na]+, 281 [M+H]+, 263 [(M+H)-H2O]
+, 
245 [(M+H)-2H2O]+. 
8-(3,4-Dihydroxy-2-methylene-butanoyloxy)-dehydro-
melitensin (2): amorphous solid; 1H-NMR (500 MHz, 
CD3OD)  (ppm) 6.37 (1H, s, H-5'a), 6.06 (1H, s, H-5'b), 
6.06 (1H, d, J = 2.8 Hz, H-13a), 5.85 (1H, dd, J = 17.4, 10.7 
Hz, H-1), 5.60 (1H, d, J = 2.8 Hz, H-13b), 5.42 (1H, s, H-3), 
5.33 (1H, dt, J = 10.8, 4.1 Hz, H-8), 5.03 (1H, d, J = 10.7, H-
2a), 5.01 (1H, s, H-3), 5.01 (1H, d, J = 17.4, H-2b), 4.59 
(1H, dd, J = 6.1, 4.0 Hz, H-3'), 4.50 (1H, m, H-6), 4.06 (1H, 
d, J = 15 Hz, H-15a), 3.96 (1H, d, J = 15 Hz, H-15b), 3.70 
(1H, dd, J = 11.3, 4.0 Hz, H-4’a), 3.50 (1H, dd, J = 11.2, 6.1 
Hz, H-4'b), 3.08 (1H, dt, J = 10.8, 2.8 Hz, H-7), 2.52 (1H, d, 
J = 11.5 Hz, H-6), 1.95 (1H, dd, J = 12.8, 4,1 Hz, H-9a), 
1.75 (1H, t, J = 11.3 Hz, H-9b), 1.19 (3H, s, H-14). 13C-
NMR (125 MHz, CD3OD)  (ppm) 170.1 (C-12), 165.2 (C-
1'), 146.5 (C-1), 144.2 (C-4), 140.8 (C-2'), 137.6 (C-11), 
125.2 (C-5'), 118.4 (C-13), 112.0 (C-3), 111.6 (C-2), 78.7 
(C-6), 70.5 (C-3’), 69.5 (C-8), 65.4 (C-15), 65.2 (C-4'), 51.8 
(C- 7), 50.4 (C-5), 44.6 (C-9), 41.6 (C-10), 17.7 (CH3). 
ESIMS m/z 379 [M+H]+, 396 [M+NH4]
+, 428 
[M+NH4+MeOH]
+. 
Cnicin (3): white crystals. 1H NMR and MS data are 
identical with those published in [4]. 
Apigenin (4), hispidulin (5), salvigenin (6), eupatorin (7), 
3'-methyleupatorin (8) and isokaempferide (9): yellow or 
pale yellow crystals. 1H and 13C NMR and MS data were 
identical with those published in the literature [4-6]. 
3.2. Xanthine Oxidase Inhibitory Assay 
Inhibition of xanthine oxidase activity was measured by 
using the protocol recommended by Sigma-Aldrich, and re-
adapted to an assay volume of 300 L, and published in de-
tail previously [7]. The substrate and the enzyme solutions 
were prepared immediately before use. The reaction mixture 
contained an 80 mM sodium pyrophosphate buffer (pH=8.5), 
0.120 mM xanthine, and 0.1 unit of XO. The absorption at 
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295 nm, indicating the formation of uric acid at 25 °C, was 
monitored and the initial rate was calculated. The extracts, 
initially dissolved and diluted in the buffer, were incorpo-
rated in the enzyme assay to assess their inhibitory activity at 
a final concentration of 200 μg/mL. The isolated compounds 
(1–9) were also tested for XO-inhibitory activity, and for 
compounds whose solutions possessed enzymatic inhibition 
higher than 35%, the IC50 values were determined. A nega-
tive control (blank; 0% XO inhibition activity) was prepared 
containing the assay mixture without the analyt. The XO-
inhibitory activity was expressed as the percentage of inhibi-
tion of XO in the above-mentioned assay system, calculated 
as follows 
Percentage of inhibition = [test inclination/(blank inclina-
tion)]  100, 
where test inclination is the linear change in the absorbance 
per minute of the test material, and blank inclination is the 
linear change in the absorbance per minute of the blank. 
3.3. DPPH Assay 
The measurement of DPPH free radical scavenging activ-
ity was carried out according to the method of Qian Shen et 
al. with some modifications. The measurement was carried 
out on a 96 well microplate. Microdilution series of samples 
(1 mg/mL, dissolved in MeOH) were prepared starting with 
150 L. To each well 50 L of DPPH reagent (100 M, 
made with MeOH) was added to gain 200 L working vol-
ume. The microplate was stored at room temperature in dark 
conditions. The absorbance was measured after 30 minutes 
at 550 nm using a BMG Labtech FluoStar Optima 
platereader. For the blank control MeOH was used instead of 
the sample. Quercetin (0.1 mg/mL, in MeOH) was used as a 
positive control. The evaluation of EC50 values were carried 
out with help of Graphpad Prism 6.05.  
The EC50 value of quercetin was 1.14 ± 0.04 g/mL. 
Samples were declared to be “Inactive” when the scavenging 
activity were below 20% at the highest tested concentration. 
The EC50 value could not be evaluated. The scavenging ac-
tivity was calculated according to the formula below: 
Inhibition (%) = (A0-As)/A0*100, 
where A0 is the absorbance of blank control, and As is the 
absorbance of sample. 
4. RESULTS AND DISCUSSIONS 
As a preliminary investigation, the dried plant material 
was extracted with MeOH and the MeOH extract was sub-
jected to solvent-solvent partition, yielding n-hexane-, 
CHCl3- and aqueous MeOH-soluble phases. These extracts 
were investigated for their XO-inhibitory activity. The high-
est activity was exerted by the CHCl3 phase with IC50 value 
of 98.98 ±15.77 g/mL, the other fractions showed only low 
activity in the tested 200 g/mL concentration. The most 
active CHCl3 extract was selected for further investigation. 
In the course of the preparative work, C. virgata was ex-
tracted with MeOH, and after evaporation the same solvent-
solvent extraction procedure was made as in case of prelimi-
nary investigation. The CHCl3 extract was subjected to open 
column chromatography on silica gel using a gradient system 
of n-hexane–acetone –MeOH. Fractions of this chromatog-
raphy were subjected to a multistep chromatographic separa-
tion and purification procedure, including OCC, VLC, CPC, 
and preparative TLC, to yield pure compounds 8-hydroxy-
sonchucarpolide (1), 8-(3,4-dihydroxy-2-methylene-
butanoyloxy)-dehydromelitensine (2), cnicin (3), apigenin 
(4), hispidulin (5), salvigenin (6), eupatorin (7), 3’-
methyleupatorin (8), and isokaempferide (9) (Fig. 1). 
The compounds were identified by ESIMS and NMR 
spectroscopy (1H-NMR, JMOD, 1H-1H COSY, NOESY, 
HSQC and HMBC), and comparison with authentic stan-
dards. Among the isolated compounds sesquiterpenes, 8-
hydroxysonchucarpolide (1), 8-(3,4-dihydroxy-2-
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Fig. (1). Structures of compounds 19. 
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methylene-butanoyloxy)-dehydromelitensine (2), cnicin (3), 
and flavones, salvigenin (6) and 3’-methyleupatorin (8) were 
isolated for the first time from C. virgata. Previously, api-
genin (4), hispidulin (5), eupatorin (7) and isokaempferide 
(9) were described by Öksüz et al. [9] from the 80% ethano-
lic extract of the aerial parts of the plant. This group also 
reports the presence of flavone aglycons (jaceosidin and ne-
petin), and glycosides (kaempferol 3-O-glucoside, isoscha-
ftoside and isovitexin) in the plant. Most probably, in our 
experiment the glycosides could not be isolated because the 
investigated CHCl3 extract contained more lipophilic con-
stituents. 
The sesquiterpenes of C. virgata was studied by an Ira-
nian group. In their study, the antimicrobial activity of ses-
quiterpene lactone-containing extract was analysed without 
compound identification, and high activity was demonstrated 
against Bacillus subtilis, Proteus vulgaris, Staphylococcus 
aureus and Escherichia coli [10]. Sesquiterpenes identified 
in our experiment belong to eudesmanolide, 2,3-seco-
eudesmanolide and germacranolide groups. Cnicin (3) and 
8	-(3,4-dihydroxy-2-methylene-butanoyloxy)-dehydromeli-
tensin (2) are structurally related as regards the substitution 
pattern, and it can be supposed that 8	-(3,4-dihydroxy-2-
methylene-butanoyloxy)-dehydromelitensin (2) is formally 
the Cope rearrangement product of cnicin (3) [11]. Ses-
quiterpenes 1 and 2 are very rare in the Centaurea genus. 
This is the third isolation of 8	-hydroxysonchucarpolide (1), 
previously only from C. zuccariniana and Onopordum cy-
narocephalum were isolated [12, 13]. As a result of our 2D 
NMR investigations, unpublished spectroscopic data were 
determined for 8	-hydroxysonchucarpolide (1) and 8	-(3,4-
dihydroxy-2-methylene-butanoyloxy)-dehydromelitensine 
(2) as listed in the Experimental part. 
The isolated compounds (1–9) were evaluated for their 
XO inhibitory activity (Table 1).  
Sesquiterpenes were proved to be inactive, and flavones 
with 5,7,4’-trihydroxy substitution were the most effective 
XO inhibitors [apigenin (4) IC50 value 0.99 ± 0.33 μM, and 
hispidulin (5) IC50 = 4.88 ± 1.21 μM]. Hispidulin (5) contain-
ing 6-OMe group exhibited lower activity than apigenin (4), 
indicating that methoxylation at C-6 of flavones weakened 
the inhibitory effect. Moreover, isokaempferide (9) with an 
additional OMe group at C-3 exhibited only marginal XO 
inhibition (IC50 = 187.57 ± 9.44 μM) in relation to apigenin 
(4), demonstrating that 3-OMe group is unfavourable to XO 
inhibition. As regard the 6,7,4’-trimethoxyflavones (6–8), 
these compounds represent the group of low activity XO 
inhibitors, in this series slightly increasing efficacy can be 
observed in the order H-3’  OH-3’  OMe-3’ (678). 
These data are consistent with the previous results published 
for structurally similar flavonoids [14]. 
The isolated flavonoids 5–9 were also evaluated for their 
free radical scavenging activity by DPPH test in order to 
estimate their role in oxidative processes. It was found that 
none of the compounds have substantial antioxidant activity; 
therefore the reduced generation of reactive oxygen species 
may be the consequence only of XO inhibition.  
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